
Vomidon 1mg/ml Suspension
Marketer
Olcare Laboratories
Salt Composition
Domperidone (1mg/ml)
Overview Vomidon 1mg/ml Suspension
PediaGast 1mg/ml oral suspension is indicated for pediatric patients experiencing indigestion, gastroesophageal reflux, nausea, or vomiting. It accelerates gastric emptying and intestinal transit, alleviating symptoms such as bloating, satiety, and stomach upset. Administer PediaGast 1mg/ml 30 minutes prior to meals for optimal efficacy. Post-prandial administration remains effective, though absorption may be slightly reduced. Infants may require a four-times-daily regimen as directed by their physician, with at least a four-hour interval between doses, ideally before each feeding. Dosage is individualized based on the child's age, weight, and clinical presentation. Do not exceed the prescribed treatment duration without consulting a physician. If vomiting occurs within 30 minutes of ingestion, repeat the dose once the child is calm; however, avoid doubling the dose if it's near the scheduled time for the next dose. Minor, transient side effects such as dry mouth, headache, somnolence, abdominal cramping, and diarrhea may occur, typically resolving with continued use. Persistent or concerning side effects warrant immediate medical attention. Inform the prescribing physician of any prior history of allergies, cardiac conditions, hematologic disorders, congenital anomalies, respiratory compromise, pulmonary abnormalities, gastrointestinal issues, dermatological problems, hepatic impairment, or renal dysfunction. A complete medical history ensures accurate dosing and optimal treatment planning.
Primary Ingredients of Vomidon 1mg/ml Suspension
No information provided. Please provide the text you wish me to rephrase.
Uses of Vomidon 1mg/ml Suspension
Managing gastroesophageal reflux disease (GERD) | Relieving indigestion | Addressing nausea | Controlling vomiting
Major Benefits of Vomidon 1mg/ml Suspension:
Administer this medication orally, following your physician's prescribed dosage and regimen. Consult the product label for complete instructions prior to consumption. Use a measuring device for accurate dispensing. Ensure thorough shaking before each dose. Ingest Vomidon 1mg/ml Suspension on an empty stomach.
Common Side effects of Vomidon 1mg/ml Suspension:
- Dryness in mouth
- Headache
- Drowsiness
- Stomach cramp
- Diarrhea
How to use Vomidon 1mg/ml Suspension:
Administer this medication orally, following your physician's prescribed dosage and regimen. Always consult the product label for instructions prior to consumption. Use a measuring cup for accurate dispensing. Ensure thorough shaking before each dose. Consume Vomidon 1mg/ml Suspension on an empty stomach.
How Vomidon 1mg/ml Suspension works:
Metclopramide 1mg/ml oral suspension is a medication that stimulates gut motility. Its action centers on the brain's emetic control center, suppressing nausea and vomiting. Simultaneously, it enhances gastric and intestinal peristalsis, facilitating efficient food passage.
SAFETY ADVICE
KidneyCAUTION
Patients with severe kidney impairment should use Vomidon 1mg/ml Suspension cautiously. Dosage modification of Vomidon 1mg/ml Suspension might be necessary. Physician consultation is advised. Regular assessment of kidney function, especially during prolonged treatment, is recommended.
LiverCAUTION
Exercise caution when administering Vomidon 1mg/ml Suspension to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Vomidon 1mg/ml Suspension is contraindicated in children exhibiting severe liver dysfunction. Pediatric administration requires prior medical evaluation.
What if you forget to take Vomidon 1mg/ml Suspension :
If your pediatrician hasn't prescribed a different schedule, administer the forgotten dose immediately upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose to compensate, and adhere to the recommended dosage plan.
Facts to Know About Vomidon 1mg/ml Suspension
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
| Actions | Prokinetic agent with dopamine (D2) receptor antagonism |
